Wall Street Journal: Sanofi’s Dengue Vaccine Made Widely Available for First Time
“Sanofi Pasteur, the vaccines division of France’s Sanofi SA, on Tuesday made the Philippines the first country where its vaccine for dengue fever will be widely available. … The vaccine, branded Dengvaxia, can be administered to people aged between nine and 45 years old. This is the first dengue vaccine in the world … The Department of Health said it is hoping to immunize one million schoolchildren in 12 months starting in April in the three most vulnerable regions of the Southeast Asian country, including the capital, Manila…” (Larano, 2/23).